These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11027621)

  • 1. Kinetin inhibits protein oxidation and glycoxidation in vitro.
    Verbeke P; Siboska GE; Clark BF; Rattan SI
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1265-70. PubMed ID: 11027621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N; Moh A; Takebayashi S
    Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N(6)-Furfuryladenine, kinetin, protects against Fenton reaction-mediated oxidative damage to DNA.
    Olsen A; Siboska GE; Clark BF; Rattan SI
    Biochem Biophys Res Commun; 1999 Nov; 265(2):499-502. PubMed ID: 10558897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
    Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
    J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
    Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide inhibits the formation of advanced glycation end products.
    Asahi K; Ichimori K; Nakazawa H; Izuhara Y; Inagi R; Watanabe T; Miyata T; Kurokawa K
    Kidney Int; 2000 Oct; 58(4):1780-7. PubMed ID: 11012913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
    Choi YG; Lim S
    J Immunoassay Immunochem; 2009; 30(4):386-99. PubMed ID: 19739013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of vimentin: a general mechanism of nonenzymatic glycation in human skin.
    Kueper T; Grune T; Muhr GM; Lenz H; Wittern KP; Wenck H; Stäb F; Blatt T
    Ann N Y Acad Sci; 2008 Apr; 1126():328-32. PubMed ID: 18448838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of advanced glycation end products formation on bovine serum albumin with various reducing sugars and dicarbonyl compounds in equimolar ratios.
    Luers L; Rysiewski K; Dumpitak C; Birkmann E
    Rejuvenation Res; 2012 Apr; 15(2):201-5. PubMed ID: 22533432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amount of N(omega)-(Carboxymethyl)arginine generated in collagen and bovine serum albumin during glycation reactions is significantly different.
    Iijima K; Fujimoto D; Irie S
    Connect Tissue Res; 2007; 48(5):271-6. PubMed ID: 17882703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of anti-methylglyoxal/glyoxal activity of three phytosterols using glycated bovine serum albumin models.
    Sobhy R; Shen Q; Abd-Elrahman AA; Khalifa I; Liang H; Li B
    Steroids; 2020 Sep; 161():108678. PubMed ID: 32565405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
    Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
    Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation.
    Miyata T; Ueda Y; Asahi K; Izuhara Y; Inagi R; Saito A; VAN Ypersele DE Strihou C; Kurokawa K
    J Am Soc Nephrol; 2000 Sep; 11(9):1719-1725. PubMed ID: 10966497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased aggregation of human platelets produced by advanced glycation end products in vitro.
    Hangaishi M; Taguchi J; Miyata T; Ikari Y; Togo M; Hashimoto Y; Watanabe T; Kimura S; Kurokawa K; Ohno M
    Biochem Biophys Res Commun; 1998 Jul; 248(2):285-92. PubMed ID: 9675128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural compounds containing a catechol group enhance the formation of Nε-(carboxymethyl)lysine of the Maillard reaction.
    Fujiwara Y; Kiyota N; Tsurushima K; Yoshitomi M; Mera K; Sakashita N; Takeya M; Ikeda T; Araki T; Nohara T; Nagai R
    Free Radic Biol Med; 2011 Apr; 50(7):883-91. PubMed ID: 21195168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism for the in vivo formation of N6-furfuryladenine, kinetin, as a secondary oxidative damage product of DNA.
    Barciszewski J; Siboska GE; Pedersen BO; Clark BF; Rattan SI
    FEBS Lett; 1997 Sep; 414(2):457-60. PubMed ID: 9315740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected elevation of pentosidine formation in collagen incubated with glucose by low concentrations of the AGE-inhibitor aminoguanidine.
    Urios P; Grigorova-Borsos AM; Sternberg M
    Diabetologia; 2004 May; 47(5):959-61. PubMed ID: 15170500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.